For these reasons, any case of decrease in or lack of CD79a expression makes the diagnosis of B-ALL very challenging, especially in laboratories in developing countries, where flow cytometry analyses are not always available to help in diagnosis of AL and, when they are, they are limited in the number of markers used for lineage assignment. Here, CD79A is linked to acute lymphoblastic leukemia.